Business Context and Reporting Period
Promis Neurosciences Inc. (PMN), a company incorporated in Ontario, Canada, filed this Form 8-K Current Report on May 20, 2026. The filing documents the results of the Company's 2026 Annual Meeting of Stockholders held on the same date.
Key Financial Metrics
This filing is a corporate governance report and does not contain financial performance data. The text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes and Voting Results
Shareholders voted on three proposals at the Annual Meeting. Of the 8,967,693 Common Shares outstanding, 4,762,024 shares (approximately 53.1%) were present or represented by proxy.
- Proposal 1 (Election of Directors): All seven nominees were elected. Broker non-votes totaled 614,643.
- Proposal 2 (Auditor Ratification): Shareholders ratified the appointment of Baker Tilly US, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. There were 4,657,634 votes for, 4,415 against, and 99,975 abstentions.
- Proposal 3 (Equity Plan Amendment): Shareholders approved an amendment to the 2025 Stock Option and Incentive Plan to increase the number of Common Shares available for issuance by 900,000. There were 3,352,388 votes for, 774,193 against, and 20,800 abstentions. Broker non-votes totaled 614,643.
Guidance, Outlook, and Risks
The filing does not contain management commentary on future guidance, outlook, risks, contingencies, or unusual items. The primary focus is the administrative approval of the equity plan amendment and the election of the board.
Investor Verification Checklist
- Verify the full text of the Amendment No. 1 to the 2025 Stock Option and Incentive Plan (Exhibit 10.1) to understand specific terms of the 900,000 share increase.
- Review the Definitive Proxy Statement on Schedule 14A filed on April 9, 2026, for detailed descriptions of the proposals and director biographies.
- Confirm the total number of shares outstanding (8,967,693) and the impact of the new share reserve on potential dilution.
- Check subsequent filings for the Company's financial results, as this 8-K contains no financial data.